Moderna Says CCP Virus Vaccine Nearly 95 Percent Effective

Moderna Says CCP Virus Vaccine Nearly 95 Percent Effective
A nurse prepares a blinded study experimental vaccine for the CCP virus, developed by the National Institutes of Health and Moderna, in Binghamton, N.Y., on July 27, 2020. Hans Pennink/AP Photo
Tom Ozimek
Tom Ozimek
Reporter
|Updated:

A vaccine candidate jointly developed by Moderna and the National Institutes of Health (NIH) has been shown in early results to be 94.5 percent effective.

Biotech company Moderna said in a statement on Nov. 16 that an analysis of its clinical trial by an independent data and safety monitoring board shows that its experimental vaccine is highly effective at preventing infection by the CCP virus.
Tom Ozimek
Tom Ozimek
Reporter
Tom Ozimek is a senior reporter for The Epoch Times. He has a broad background in journalism, deposit insurance, marketing and communications, and adult education.
twitter
Related Topics